, the call for more and better data has grown gradually louder: good information to help equip researchers with understanding of the virus -- and options to fight it.-- shown as safe over decades of use, and widely touted for its promise. Yet it must face further clinical trial.
Convalescent plasma, the yellow liquid separated from the blood of recovered COVID-19 patients, is thought a viable way to help others fight off or recover from the disease. Antibodies found in that plasma - antibodies already proven their mettle at beating the virus - are then harvested, and deployed to treat the new sick.
A lab at Methodist Dallas Medical Center prepares viral transport media for samples before collecting samples for coronavirus disease in Dallas, June 24, 2020. "The goal is to offer this to as many consecutive patients as possible," Dr. Hollis O'Neal told ABC News. His team at LSU Health Sciences Center in Baton Rouge, Louisiana, has joined the Vanderbilt trial."We're doing this trial because number one, we don't know that it works. We don't know the answer -- that's what we're trying to figure out. And I don't think you can ever say any single trial is the definitive answer -- but this could get us close.
Of course it was her.
Been trying to tell y’all for years that she is awesome.
DollyParton WeAreBetterTogether GoodNews
Suddenly I don't trust Dolly
That's no antibiotic
tedgioia DollyParton 🙌🏼
NEW JERSEY FRONTLINE Dr. SOLIMAN... COVID19 CORONAVIRUS HOSPITAL TREATMENT modes... cheaper Steroids Dexamethasone ...cheaper Azithromycin Zinc Plaquenil or HYDROXYCHLOROQUINE works wonder